Abbott Laboratories (NYSE:ABT) Shares Sold by Narwhal Capital Management
Narwhal Capital Management cut its position in shares of Abbott Laboratories (NYSE:ABT – Free Report) by 25.9% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 23,208 shares of the healthcare product maker’s stock after selling 8,115 shares during the quarter. Narwhal Capital Management’s holdings […]
More Stories
Blackstone (NYSE:BX) Price Target Raised to $179.00
Blackstone (NYSE:BX – Get Free Report) had its price objective hoisted by stock analysts at Piper Sandler from $168.00 to...
Botswana Diamonds (LON:BOD) Shares Up 36.9% – Here’s What Happened
Botswana Diamonds plc (LON:BOD – Get Free Report) traded up 36.9% during mid-day trading on Monday . The stock traded...
Botswana Diamonds (LON:BOD) Shares Up 36.9% – Time to Buy?
Botswana Diamonds plc (LON:BOD – Get Free Report) shares rose 36.9% during mid-day trading on Monday . The stock traded...
Varex Imaging Corporation Closes Private Offering of $125 Million in Senior Secured NotesSalt Lake City, December 23, 2024 – Varex Imaging Corporation (Nasdaq: VREX) successfully closed a private offering of $125 million aggregate principal amount of
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...
Versarien (LON:VRS) Shares Up 3.4% – Here’s Why
Versarien plc (LON:VRS – Get Free Report)’s share price shot up 3.4% on Monday . The company traded as high...
Ennis (NYSE:EBF) Releases Earnings Results, Meets Estimates
Ennis (NYSE:EBF – Get Free Report) announced its quarterly earnings results on Monday. The industrial products company reported $0.39 EPS...